北米の医薬品受託販売組織の2030年までの市場予測 - 地域分析 - サービス(商用サービスおよび非商用サービス)、モジュール(シンジケートモジュールおよび専用モジュール)、治療分野(心血管疾患、腫瘍学、代謝性疾患、神経学、整形外科疾患別) 、感染症など)、およびエンドユーザー(バイオ医薬品会社および製薬会社)

BMIRE00030017 | Pages: 86 | Pharmaceuticals | Apr 2024 | Type: Regional | Status: Published
北米の医薬品受託販売組織市場は、2022年の39億8,729万米ドルから、2030年までに76億1,412万米ドルに成長すると予想されています。2022年から2030年までに8.4%のCAGRを記録すると推定されています。デジタルテクノロジーの統合が北米を牽引医薬品受託販売組織市場 デジタルテクノロジーの展開の増加により、医薬品受託販売組織(CSO)市場の変革的な急増が促進されています。この根本的な変化は、動的に変化する医薬品市場への戦術的な対応の必要性を浮き彫りにしています。営業業務を合理化し、生産性を向上させ、デジタル化が進む複雑な医療環境に対処するために不可欠な要素は、デジタル ツールとテクノロジーを CSO に統合することです。高度な顧客関係管理ツール、人工知能、データ分析を使用して、CSO は貴重な洞察を取得し、販売戦略をカスタマイズし、医療専門家とより深い関係を確立できます。情報伝達の高速化に加えて、デジタル プラットフォームのシームレスな統合により、市場動向や法改正へのリアルタイムの適応が可能になります。製薬 CSO の状況におけるこの技術的変化は、単なる流行ではありません。これは、販売戦術がどのように開発され、実行されるかについての根本的な再定義を意味します。デジタル テクノロジーの導入により、CSO はイノベーションの最前線に立つことになります。これは、医療分野を席巻する大規模なデジタル変革に合わせて、より応答性の高い環境を促進します。製薬業界の最高責任者(CSO)が技術的専門知識の融合、戦略的な機敏性、製薬エコシステムの現代的な需要の明確な認識によって推進されるデジタル化の力を活用し続けているため、この市場は持続的な成長に向けた態勢が整っています。北米の医薬品受託販売組織市場の概要 北米の医薬品受託販売組織市場は、米国、カナダ、メキシコに分割されています。 2022 年には、米国がこの地域で最大の市場シェアを保持し、予測期間中もその優位性が続くと予想されます。北米の医薬品受託販売組織市場は、受託販売組織による新技術の導入、製薬会社による低分子医薬品やバイオ医薬品の売上拡大への重点の高まり、医薬品の医薬品販売受託事業への注力の増加により、成長が見込まれています。社内販売業務にかかるコストの削減は、北米の医薬品受託販売組織市場の成長を促進する主な要因です。新薬の発売数は時間の経過とともに急増しました。研究開発動向に関する IQVIA のレポートによると、2021 年に世界中で 84 の新しい活性化合物が導入されました。これは、過去 5 年間に導入された数の 2 倍です。国際的に医薬品の発売が増加するにつれて、契約販売サービスの需要が高まることが予想されます。北米は医薬品受託販売組織市場で最大のシェアを占めています。 EPS Corp.などの主要企業。 IQVIA株式会社;そして Axxelus がこの地域の市場を活性化しています。北米の医薬品受託販売組織市場の収益と2030年までの予測(百万米ドル) 北米の医薬品受託販売組織の市場セグメンテーション 北米の医薬品受託販売組織の市場は、サービス、モジュール、治療領域、エンドユーザー、および国に分割されています。サービスに基づいて、北米の医薬品受託販売組織市場は商用サービスと非商用サービスに二分されます。商用サービスセグメントは、2022年の北米の医薬品受託販売組織市場で大きなシェアを占めました。モジュールに基づいて、北米の医薬品受託販売組織市場はシンジケートモジュールと専用モジュールに二分されます。シンジケートモジュールセグメントは、2022年の北米の医薬品受託販売組織市場で大きなシェアを占めました。北米の医薬品受託販売組織市場は、治療領域に基づいて、心血管疾患、腫瘍学、代謝障害、神経学、整形外科疾患、感染症に分類されます。病気、その他。オンコロジー部門は、2022年の北米の医薬品受託販売組織市場で最大のシェアを占めました。エンドユーザーに基づいて、北米の医薬品受託販売組織市場はバイオ医薬品会社と製薬会社に二分されます。製薬会社セグメントは、2022年の北米の医薬品受託販売組織市場で大きなシェアを占めました。国に基づいて、北米の医薬品受託販売組織市場は米国、カナダ、メキシコに分割されています。 2022 年の北米の医薬品受託販売組織市場は米国が独占しました。Aenova Holding GmbH、Axxelus Inc、CMIC Holdings Co Ltd、IQVIA Holdings Inc、Peak Pharma Solutions Inc、Pfizer Inc、Promoveo Health LLC、QFR Solutions LLC、Sales Focus Inc、 Syneos Health Inc は、北米の医薬品受託販売組織市場で事業を展開する大手企業の一部です。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Integration of Digital Technologies

5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products

5.2 Key Market Restraints

5.2.1 Quality Issues Associated with Outsourcing

5.3 Key Market Opportunities

5.3.1 Rising Use of Telemedicine and Remote Detailing

5.4 Key Future Trends

5.4.1 Expansion in Emerging Markets

5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis

6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview

7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

7.3 Commercial Services

7.3.1 Overview

7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Commercial Services

7.4.1 Overview

7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview

8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

8.3 Syndicated Modules

8.3.1 Overview

8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Dedicated Modules

8.4.1 Overview

8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview

9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

9.3 Cardiovascular Disorders

9.3.1 Overview

9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Metabolic Disorders

9.5.1 Overview

9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Neurology

9.6.1 Overview

9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.7 Orthopaedic Diseases

9.7.1 Overview

9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.8 Infectious Diseases

9.8.1 Overview

9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Biopharmaceutical Companies

10.3.1 Overview

10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 North America

11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country

11.1.1.2 US

11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Canada

11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

11.1.1.4 Mexico

11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)

11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)

11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)

11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies

12.2.1 Overview

13. Company Profiles

13.1 CMIC Holdings Co Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Axxelus Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 IQVIA Holdings Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Peak Pharma Solutions Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QFR Solutions LLC

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Promoveo Health LLC

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Syneos Health Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Aenova Holding GmbH

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Pfizer Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Sales Focus Inc

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

?

List of Tables

Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation

Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)

Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)

Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)

Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market

Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market

?

List of Figures

Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country

Figure 2. North America - PEST Analysis

Figure 3. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)

Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)

Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)

Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue (2022) (US$ Million)

Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)

Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)

1. Aenova Holding GmbH

2. Axxelus Inc

3. CMIC Holdings Co Ltd

4. IQVIA Holdings Inc

5. Peak Pharma Solutions Inc

6. Pfizer Inc

7. Promoveo Health LLC

8. QFR Solutions LLC

9. Sales Focus Inc

10. Syneos Health Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Pharmaceutical Contract Sales Organizations Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440